Related Experiment Videos
Enhanced external counterpulsation
Theresa Ann Brosche1, Susan Kay Middleton, Ronald G Boogaard
1Germanna Community College-Nursing, USA. tbrosche@aol.com
Dimensions of Critical Care Nursing : DCCN
|February 22, 2005
Summary
Enhanced external counterpulsation (EECP) offers a noninvasive treatment for refractory ischemic heart disease, improving quality of life. This therapy reduces symptoms and increases patient activity levels, providing significant benefits.
Area of Science:
- Cardiology
- Medical Devices
- Noninvasive Therapies
Background:
- Refractory ischemic heart disease significantly impacts daily living and quality of life.
- Patients often experience limitations in physical activity and may require bed rest.
- Current medical management may not be sufficient for all patients with severe ischemic heart disease.
Observation:
- Enhanced external counterpulsation (EECP) is an outpatient procedure.
- EECP aims to alleviate symptoms and enhance patient functional capacity.
- Evidence-based research supports the efficacy of EECP therapy.
Findings:
- EECP therapy has demonstrated improvements in patient quality of life.
- The procedure effectively decreases ischemic symptoms.
- EECP enables patients to increase their physical activity levels.
Implications:
- EECP provides a viable noninvasive treatment option for refractory ischemic heart disease.
- Improved symptom management and increased activity can lead to better patient outcomes.
- Further research and clinical application of EECP can benefit patients with limited mobility.